ExploreConditionvincristine-induced neuropathy
Condition

vincristine-induced neuropathy

Also known as: vincristine-induced neuropathy vincristine-induced neuropathy; pediatric cancer
6 findings 1 paper 5 related entities View in graph →

Related entities

interventions
outcomes
populations
studys

Findings (50)

None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Size: 8.42 points higher on PedsQL total score
None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

None
improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Papers (1)